State Street’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,886,181
| Closed | -$78.3M | – | 4832 |
|
|
2021
Q3 | $78.3M | Buy |
3,886,181
+1,297,119
| +50% | +$35.8M | ﹤0.01% | 1461 |
|
|
2021
Q2 | $96.6M | Sell |
2,589,062
-456,495
| -15% | -$14M | 0.01% | 1322 |
|
|
2021
Q1 | $77.9M | Buy |
3,045,557
+225,458
| +8% | +$5.76M | ﹤0.01% | 1419 |
|
|
2020
Q4 | $62.1M | Sell |
2,820,099
-319,274
| -10% | -$7.03M | ﹤0.01% | 1500 |
|
|
2020
Q3 | $56.5M | Buy |
3,139,373
+272,178
| +9% | +$5.64M | ﹤0.01% | 1368 |
|
|
2020
Q2 | $72.8M | Buy |
2,867,195
+1,184,110
| +70% | +$25.5M | 0.01% | 1178 |
|
|
2020
Q1 | $30.9M | Buy |
1,683,085
+24,815
| +1% | +$482K | ﹤0.01% | 1559 |
|
|
2019
Q4 | $36.5M | Sell |
1,658,270
-124,675
| -7% | -$2.51M | ﹤0.01% | 1736 |
|
|
2019
Q3 | $25.6M | Sell |
1,782,945
-12,833
| -0.7% | -$183K | ﹤0.01% | 1898 |
|
|
2019
Q2 | $28.3M | Sell |
1,795,778
-85,805
| -5% | -$1.17M | ﹤0.01% | 1874 |
|
|
2019
Q1 | $27.6M | Sell |
1,881,583
-163,307
| -8% | -$1.88M | ﹤0.01% | 1836 |
|
|
2018
Q4 | $21.9M | Buy |
2,044,890
+1,247,187
| +156% | +$16.4M | ﹤0.01% | 1919 |
|
|
2018
Q3 | $12.2M | Buy |
797,703
+58,251
| +8% | +$848K | ﹤0.01% | 2473 |
|
|
2018
Q2 | $9.06M | Buy |
739,452
+716,869
| +3,174% | +$9.01M | ﹤0.01% | 2578 |
|
|
2018
Q1 | $216K | Buy |
22,583
+12,262
| +119% | +$132K | ﹤0.01% | 3551 |
|
|
2017
Q4 | $94K | Buy |
+10,321
| New | +$75.9K | ﹤0.01% | 3609 |
|
|
2016
Q2 | – | Sell |
-209,015
| Closed | -$1.12M | – | 3792 |
|
|
2016
Q1 | $1.12M | Buy |
209,015
+35,820
| +21% | +$226K | ﹤0.01% | 3193 |
|
|
2015
Q4 | $2.06M | Buy |
173,195
+30,454
| +21% | +$348K | ﹤0.01% | 2988 |
|
|
2015
Q3 | $1.17M | Buy |
142,741
+15,796
| +12% | +$182K | ﹤0.01% | 3173 |
|
|
2015
Q2 | $1.77M | Buy |
126,945
+69,434
| +121% | +$1.27M | ﹤0.01% | 3100 |
|
|
2015
Q1 | $1.38M | Sell |
57,511
-6,051
| -10% | -$136K | ﹤0.01% | 3151 |
|
|
2014
Q4 | $1.05M | Sell |
63,562
-4,719
| -7% | -$54.5K | ﹤0.01% | 3252 |
|
|
2014
Q3 | $870K | Buy |
68,281
+4,829
| +8% | +$72.8K | ﹤0.01% | 3285 |
|
|
2014
Q2 | $1.43M | Buy |
63,452
+34,807
| +122% | +$631K | ﹤0.01% | 3164 |
|
|
2014
Q1 | $809K | Buy |
+28,645
| New | +$1.06M | ﹤0.01% | 3286 |
|
Other funds holding DRNA
State Street's DRNA Position: Q4 2021 in Review
State Street sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 3,886,181 shares — an estimated $78.3M sold.
State Street first reported a position in DRNA in Q1 2014 and held it in 25 quarters. The position peaked at $96.6M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- State Street reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- State Street sold 3,886,181 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $78.3M.
- State Street first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 25 quarters.
- State Street's Dicerna Pharmaceuticals, Inc. position peaked at $96.6M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on State Street's 13F filing for Q4 2021, filed 14 Feb 2022.